Skip to content

Sevoflurane in paediatric cardiac surgery

Optimising sevoflurane administration during paediatric cardiopulmonary bypass

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028315
Enrollment
88
Registered
2020-10-09
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Q20- Congenital malformations of cardiac chambers and connections

Interventions

Control Intervention1: Sevoflurane volatile anaesthetics used routinely in all paediatric cardiac surgery: Sevoflurane 1% Vs Sevflurane 2% dial settings of vaporiser in anaesthesia.

Sponsors

Army Hospital Research and Referral
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Paediatric patients ( <18 yrs) undergoing on pump cardiac surgery at Army Hospital R&R, for acyanotic congenital heart surgeries will be included in the study.

Exclusion criteria

Exclusion criteria: Patients in whom epidural catheter is not inserted due to various reasons ( patient refusal, infection over the spine, coagulation disorders, emergency cases, suprasystemic PAH, any association with syndrome, patients with dysrhythmias, patient on intraââ?¬â??aortic balloon counter pulsation (IABP), and patient on antiplatelet agent, low molecular weight heparin or heparin infusion), patients with preoperative renal dysfunction and on ion-tropes will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Serum Trop ITimepoint: preoperatively (T0), 4-hr (T1), one (T2) and two (T3) days after surgery

Secondary

MeasureTime frame
NGALTimepoint: preoperatively (T0), 4-hr (T1), one (T2) and two (T3) days after surgery

Countries

India

Contacts

Public ContactAlok Kumar

Army Hosp RR

mipayal07@gmail.com8146044104

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026